This study was requested by LaDou, who was acting as guest editor for a special issue of Clinics concentrating on health issues in the electronics industry. IBM claimed the data was confidential but lawyers said the paper was a public document. LaDou sent it off for publication.
"I got an e-mail back very quickly, telling me that the paper was not suitable for publication," he said.
Elsevier says the study is a research paper and only review papers are accepted. LaDou described this claim as "nonsense."
Elsevier also denied it had been pressed by any outside company or party into pulling the paper, and claimed it was hoping to work with the journal's contributors to try to find an alternative journal for Clapp's paper -- though not necessarily one owned by the company.
RSS